Virios Therapeutics (VIRI) Reports Q2 Loss of $0.51/sh

Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.51), versus ($0.14) reported last year.

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch
• Prabhudas Lilladher Upgrades GE Vernova T&D India (GVTD:IN) to Buy (1)